B2

Dr. Junbo Ge is a world-renowned expert in cardiovascular medicine, one of the leading figures in China's interventional cardiology field, and an Academician of the Chinese Academy of Sciences. He serves as Chief Scientist at Parkway Shanghai Hospital, Director of the Pan-Vascular Disease Center, Director of the Department of Cardiology at Zhongshan Hospital affiliated with Fudan University, Professor and Doctoral Supervisor, Director of the Shanghai Institute of Cardiovascular Diseases, Dean of the Institute of Biomedical Sciences at Fudan University, Director of the National Clinical Research Center for Interventional and Radiological Therapeutics, and President of the Chinese College of Cardiovascular Physicians. He formerly served as Chairman of the Cardiology Branch of the Chinese Medical Association and President of the Asian Pacific Society of Interventional Cardiology.

Academician Ge has long been engaged in clinical and scientific research in cardiovascular diseases, dedicated to optimizing treatment strategies and technological innovation for coronary artery disease. He has achieved groundbreaking accomplishments in intravascular ultrasound technology, development of novel coronary stents, interventional strategies for complex coronary artery disease, and cellular therapy for coronary diseases. He was the first internationally to discover the "half-moon phenomenon" of myocardial bridges, significantly improving diagnostic and therapeutic capabilities. He performed China's first covered stent implantation for plaque rupture. He led the development of China's first biodegradable-coated coronary stent, now widely applied in over 900 hospitals nationwide. He directed the creation of China's first fully self-developed bioresorbable coronary stent (Xinsorb stent). He pioneered the "retrograde guidewire technique" internationally, conquering challenges in complex coronary lesions and establishing it as one of the standard procedures in the field. He initiated the transradial approach for coronary angiography in China. Academician Ge has been honored with the National Innovation and Excellence Medal, Bethune Medal, Ho Leung Ho Lee Prize for Scientific and Technological Progress, Fok Ying Tung Award for Outstanding Chinese Physicians, and the International Conference on Innovations in Cardiology (ICI) Lifetime Achievement Award.

Dr. Steve Huang has many years of experience in clinical practice in cardiology. He is proficient in managing common cardiovascular conditions, specializing in the diagnosis and treatment of coronary artery disease, heart failure, valvular heart disease, and cardiac arrhythmias. Dr. Huang excels in the prevention and pharmacological management of chronic diseases, including hypertension, type 2 diabetes mellitus, and dyslipidemia, with surgical expertise in coronary interventional therapy.

Dr. Huang first earned his Master's degree in Biotechnology from the University of California, Irvine (UCI), followed by a Bachelor's degree in Clinical Medicine from Peking University Health Science Center. He subsequently obtained his Doctoral degree in Clinical Medicine from Zhongshan Hospital, Fudan University, where he studied under Academician Junbo Ge. From 2002 to 2004, Dr. Huang served as a Senior Clinical Research Associate at Baxter Bioscience in Duarte, USA. In 2013, he completed clinical observership training at UCLA Olive View Medical Center. Since 2016, he has served as Attending Physician of Cardiology, Cardiology On-call Physician and Chest Pain Center Coordinator at a private hospital in Shanghai. He has accumulated extensive experience in the management of cardiovascular emergencies and critical conditions and in coronary interventional procedures. Dr. Huang has published more than 10 SCI-indexed papers, including 2 as first author.

Dr. Yanlin Li specializes in the interventional diagnosis and treatment of coronary artery disease, minimally invasive therapies for valvular heart diseases, cardiac pacemaker implantation and follow-up programming, pharmacological prevention and management of hypertension, emergency care for critical cardiovascular conditions, as well as treatment and rehabilitation of chronic heart failure.

Dr. Li received his Ph.D. in Cardiovascular Medicine from Shanghai Medical College of Fudan University, under the mentorship of Academician Junbo Ge. He began his specialized training in interventional cardiology in 2003 at Zhongshan Hospital and later joined the Department of Cardiology at Huashan Hospital, where he performed nearly 1,000 life-saving cardiovascular procedures annually as a lead interventionalist. From 2008 to 2009, he completed a specialized training program in interventional cardiology at Washington Hospital Center, Washington, D.C., USA. Dr. Li has authored or co-authored over 20 academic publications and book chapters, including 8 SCI-indexed papers. He has led or participated in research funded by the National Natural Science Foundation of China, the Shanghai Municipal Science and Technology Commission, and the Shanghai Municipal Health Commission. Dr. Li is currently a: Committee Member of the Cardiovascular Disease Specialty Committee of the Shanghai Medical Association; Committee Member of the Cardiovascular Branch of the Shanghai Medical Doctor Association; Standing Committee Member of the Non-Public Medical Institutions Cardiovascular Disease Committee; and Member of the China CTO Old Partners Group.